Research

  • Research reveals limitations of blood sugar trackers

    Blood sugar tracking devices may not give accurate readings for people without diabetes, new research suggests. Continuous glucose monitors (CGMs) – small wearable devices fitted to the arm or abdomen – send real-time blood sugar data to an app, showing how glucose levels rise and fall throughout the day. Researchers analysed CGM data from 972 [...]

  • Data driven simulation model could help combat the US opioid crisis

    A team of scientists have developed a data-driven simulation model designed to help policymakers better understand and address the United States' opioid crisis. Researchers report that the model, known as SOURCE (Simulation of Opioid Use, Response, Consequences, and Effects), presents the most detailed model to date of the crisis. It does that by capturing how [...]

  • Building trust, driving adoption: Evidence-led marketing

    By Jasmin Hounsell, co-founder of Evolene Ltd. After device development and regulatory clearance, it feels like it should be an easier ride for medical device developers. However, adoption and implementation are the next big hurdles to overcome. Clinicians are highly educated, meaning that communication needs to both inform and build trust – they will not [...]

  • AI-powered test accurately screens hearing at home without clinical supervision

    An AI-powered hearing test is reliably able to check your hearing on a computer or smart phone without clinical supervision according to a study The high-tech hearing tests, they say, can efficiently understand human speech from the comfort of your own home, rather than at a hospital clinic, by using AI to screen out background [...]

  • Skin sensing technology could transform eczema and psoriasis treatment

    An innovative technology developed by researchers in the UK has received over £475,000 in funding to revolutionise how eczema is diagnosed and treated, potentially ending years of suffering for millions of patients across the UK. The innovative vibroacoustic sensor, which measures material changes in each layer of skin using small vibrations on the surface, has [...]

  • University spin-out raises £2m for gene-editing tool

    A UK company that has developed a novel gene-editing tool has raised £2m to expand its commercial work developing bacteria strains and adapt its tool for use with human and animal cells. Forge Genetics, a spin-out from the University of Nottingham, has secured funding from the Midlands Engine Investment Fund II, through its appointed fund [...]

  • Amorphical announces positive interim results from ongoing Crohn’s trial

    Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, has announced positive interim results from its ongoing open-label clinical trial evaluating its investigational therapy for the treatment of moderate-to-severe Crohn’s disease. The data suggests that the investigational therapy, when added to best available therapy, supports meaningful clinical improvement and remission. The drug has been [...]

  • Briya and Tanner Health partner to accelerate clinical innovation and improve patient care

    Briya has announced a strategic partnership with Tanner Health on the creation of the Briya/Tanner Network, a new patient data network to support clinical innovation and healthcare research by providing secure access to high-quality real-world data (RWD). The collaboration integrates Briya's secure data access platform with Tanner’s extensive patient network. It demonstrates Briya's commitment to [...]

  • AI breakthroughs predict painful crises in sickle cell disease before they strike

    Millions of patients worldwide living with sickle cell disease (SCD) could soon have the power to anticipate painful vaso-occlusive crises (VOCs) before they occur, thanks to an artificial intelligence platform developed by Sanius Health, a London-based digital health company. Sanius Health uses predictive analytics to forecast crises with up to 92% sensitivity, giving patients actionable [...]

  • Why addressing cardiovascular disease is so important to the NHS 10 Year Plan

    By Dr Eleanor Wicks, Cardiologist and Clinical Lead, Lifeyear Cardiovascular disease (CVD) is the UK’s biggest killer causing over a quarter of all deaths in the UK according to the British Heart Foundation. That’s not a point of debate, it’s the reality that sits behind so many overwhelmed wards, waiting rooms and exhausted staff. CVD [...]